Analyst Chandan Taparia Highlights Three Stocks for Potential Focus on May 22 2026 IBEX Q1 2026 Earnings Earnings Beat Lifts Shares as Company Demonstrates Operational Discipline NVCT Q1 2026 Earnings BetterthanExpected Loss Narrower as Company Advances Pipeline Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026 LPA Q1 2026 Earnings Loss Per Share of 025 Amid Logistics Property Market Headwinds